It is well known that inhibition of the MVA pathway by statins impairs oncogenic functions of YAP/TAZ in a variety of cancer types (Sorrentino et al, 2014; Wang et al, 2014; Mi et al, 2015; Mullen et al, 2016). The gene discussed is YAP1; the disease is cancer.